期刊文献+

CD44 RNAi对EJ细胞增殖、迁移及其与特异性单抗结合力的影响 被引量:3

CD44 knockdown decreases immuno-bounding to the monoclonal antibody KMP1 and inhibits the growth and migration of EJ cells
下载PDF
导出
摘要 目的研究EJ细胞中CD44小RNA干扰后细胞增殖、迁移功能以及其与特异性单抗KMP1结合力的改变。方法小RNA干扰的方法抑制EJ细胞中CD44表达,Western blot和流式细胞仪检测EJ细胞与CD44特异性单抗KMP1的结合功能变化,细胞划痕实验和Boyden小室检测shCD44-EJ细胞的迁移功能,[3H]掺入法检测shCD44-EJ细胞的增殖能力。结果 shCD44-EJ细胞与KMP1的结合能力下降,CD44的表达量也降低,Wide type组和shCD44-EJ组的迁移到划痕中央的细胞数分别为257±32个和132±29个,shCD44-EJ组和Vector组细胞迁移到膜中和下室中的平均细胞数为356±13和672±17个,显示shCD44-EJ细胞的迁移能力较Wide type组和Vector组分别降低52%和53%,shCD44-EJ细胞的增殖活性是Vector组的73%。结论特异性沉默CD44可降低EJ细胞与其特异性单抗KMP1的结合功能,并抑制EJ细胞的迁移和增殖能力。 Objective To investigate the effect of CD44 targeted RNA interference(RNAi) on the growth and migration of human bladder carcinoma EJ cells,and research the change of EJ cells immuno-bounding to the monoclonal antibody KMP1.Methods We transfected bladder cancer cell line EJ with well-designed CD44 siRNA.Flow cytometry and Western blot analysis were used to assess the CD44 immuno-bounding to the monoclonal antibody KMP1.Wound healing assay and Boyden chamber were used to investigate the change of shCD44-EJ cell's migration.Proliferation of cells was measured using a -thymidine incorporation assay.Results CD44 knockdown significantly decreased KMP1 staining signal compared with the EJ cells transfected by pSuper-puro empty vector control,Flow cytometry analysis found that CD44 knockdown decreases EJ cells immuno-bounding to the KMP1.Western blot analysis revealed a remarkable decrease of CD44 expression in shCD44-EJ cells,but not in pSuper-puro vector transfected.CD44silencing also significantly inhibited cell migration through wound healingassay.The modified Boyden chamber assay showed similar results also.-thymidine incorporation assay revealed that CD44 silencing can extremely decrease the proliferation of EJ cells.Conclusions CD44 silencing can effectively decrease EJ cells immuno-bounding to the monoclonal antibody KMP1 and inhibit the migration and the proliferation of EJ cells in vitro.
出处 《基础医学与临床》 CSCD 北大核心 2012年第3期313-316,共4页 Basic and Clinical Medicine
基金 云南省科技厅高层次人才培引工程经费资助项目(200807015)
关键词 膀胱癌 EJ细胞 CD44 RNA干扰 bladder carcinoma EJ cells CD44 RNA interference
  • 相关文献

参考文献10

  • 1丁明霞,李翀,左毅刚,詹辉,范祖森,王剑松.膀胱癌EJ细胞的CD44异常糖基化及其单抗KMP1的生物学功能研究[J].中国肿瘤临床,2011,38(13):759-762. 被引量:4
  • 2Jacobs BL,Lee CT,Montie JE.Bladder Cancer in 2010:How Far have We Come?[J].CA Cancer J Clin,2010,60:244-272. 被引量:1
  • 3Gallagher DJ,Milowsky MI,Gerst SR,et al.Phase II studyof sunitinib in patients with metastatic urothelial cancer[J].J Clin Oncol,2010,28:1373-1379. 被引量:1
  • 4Mitra,AP,Cote,RJ.Molecular pathogenesis and diagnos-tics of bladder cancer[J].Annu Rev Pathol,2009,4:251-285. 被引量:1
  • 5文进,李汉忠,纪志刚,严维刚,石冰冰.苹果酸舒尼替尼抑制膀胱癌T24细胞系的体外增殖[J].基础医学与临床,2011,31(9):988-990. 被引量:4
  • 6Bourguignon LY,Gilad E,Rothman K,et al.Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERKsignaling,leading to actin binding,Elk-1/estrogen receptortranscriptional activation,and ovarian cancer progression[J].J Biol Chem,2005,280:11961-11972. 被引量:1
  • 7Adamia S,Maxwell CA,Pilarski LM.Hyaluronan and hya-luronans synthases:Potential therapeutic targets in cancer[J].Curr Drug Targets Cardiovase Haematol Disord,2005,5:3-14. 被引量:1
  • 8Nagano O,Saya H.Mechanismand biological significance ofCD44 cleavage[J].Cancer Sci,2004,95:930-935. 被引量:1
  • 9Weber GF,Bronson RT,Ilagan J,et al.Absence of theCD44 gene prevents sarcoma metastasis[J].Cancer Res,2002,62:2281-2286. 被引量:1
  • 10Morrison H,Sherman LS,Legg J,et al.The NF2 tumor sup-pressor gene produet,merlin,mediates contact inhibition ofgrowth through interaetions with CD44[J].GenesDev,2001,15:968-980. 被引量:1

二级参考文献19

  • 1ParkJH, Nishidate T, Kijima K, et al. Critical roles of mucin 1 gly- cosylation by transactivated polypeptide N-acetylgalactosaminyl- transferase 6 in mammary carchlogenesis~. Cancer Res, 2010, 70 (7): 2759--2769. 被引量:1
  • 2Hanley WD, Napier SL, Burdick MM, et al. Variant isoforms of CD44 are P-and L-selecthl ligands on colon carcinoma cells[J].FASEBJ, 2006, 20(2):337-339. 被引量:1
  • 3Alves CS, Yakovlev S, Medved L, et al. Biomolecular characteriza- tion of CD44-fibrin(ogen) binding:distinct molecular requirements mediate binding of standard and variant isoforms of CD44 to im- mobilized fibrhl(ogen)[J]. J Biol Chem, 2009, 284(2) : 1177-1189. 被引量:1
  • 4Nagano O, Saya H. Mechanism and biological significance of CD44 cleavage[J].Cancer Sci, 2004, 95(12): 930-935. 被引量:1
  • 5Jemal A, Siegel R, XuJ, et N. Cancer statistics,2010[J]. CA CancerJ Clin, 2010, 60(5): 277-300. 被引量:1
  • 6Jacobs BL, Lee CT, Montie JE. Bladder cancer in 2010: how" fitr have we come[J]? CA CancerJ Clin, 2010, 60(4): 244-272. 被引量:1
  • 7Mitra AP, Cote RJ. Molecular pathogenesis and diagnostics of blad der cancer[J]. Annu Rev Pathol, 2009, 4: 251-285. 被引量:1
  • 8Skubitz AP. Adhesion molecules[J].Cancer Treat Res, 2002, 107 (2): 305-329. 被引量:1
  • 9Li CZ, Liu B, Wen ZO~ et al. Inhibition of CD44 expression by small interfering RNA to suppress the growth and metastasis of ovarian cancer cells in vitro and in vivo[J]. Folia Biol (Praha), 2008, 54(6): 180-186. 被引量:1
  • 10Du L, Wang H, He L, et al. CD44 is of functional importance for colorectal cancer stem cells[J]. Clin Cancer Res, 2008, 14(21): 6751-6760. 被引量:1

共引文献6

同被引文献15

  • 1Shammas MA, Koley H, Batchu RB, et al. Telomerase in- hibition by siRNA causes senescence and apoptosis in Barrett's adenoearcinoma cells: mechanism and therapeutic potential. [J]. Mol Cancer,2005, 4: 24. 被引量:1
  • 2Mita AC, Mita MM, Nawrocki ST,et al. Survivin : key regu- lator of mitosis and apoptosis and novel target for cancer ther- apeutics [J]. Clin Cancer Res, 2008, 14:5000-5005. 被引量:1
  • 3Hanahan D, Weinberg RA. The hallmarks of cancer [ J ]. Cell, 2000, 100:57-70. 被引量:1
  • 4Jazag A, Kanai F, Ijichi H, et al. Single small-interfering RNA expression vector for silencing multiple transforming growth factor-beta pathway components [ J ]. Nucleic Acids Res,2005, 33 :el31. 被引量:1
  • 5Hu T, Fu Q, Chen P, et al. Construction of an artificial MicroRNA expression vector for simultaneous inhibition of multiple genes in mammalian cells [ J ]. Int J Mol Sci,2009,10:2158 - 2168. 被引量:1
  • 6Junn HJ, Kirn JY, Seol DW. Effective knockdown of multi- ple target genes by expressing the single transcript harbou- ring rnulti-cistronic shRNAs [ J]. Biochem Biophys Res Comrnun, 2010, 396:861 - 865. 被引量:1
  • 7Kumari A, Srinivasan R, Wig JD. Effect of c-MYC and E2F1 gene silencing and of 5-azacytidine treatment on te- lomerase activity in pancreatic cancer-derived cell lins [J]. Pancreatology, 2009, 9:360 - 368. 被引量:1
  • 8Yuan J, Yang BM, Zhong ZH, et al. Upregulation of sur- vivin during immortalization of nontransformed human fi- broblasts transduced with telomerase reverse transcriptase [ J ]. Oncogene, 2009,28:2678 - 2689. 被引量:1
  • 9薛芳,段明英,陈燕.RNAi抑制Survivin基因表达增加细胞凋亡[J].基础医学与临床,2009,29(9):965-969. 被引量:2
  • 10储继红,许美娟,吴婷,刘史佳,张军,居文政.人参皂苷Rg3药理学及药代动力学研究进展[J].中国药物与临床,2011,11(2):180-182. 被引量:18

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部